154 related articles for article (PubMed ID: 21625233)
21. Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
Troppan K; Hofer S; Wenzl K; Lassnig M; Pursche B; Steinbauer E; Wiltgen M; Zulus B; Renner W; Beham-Schmid C; Deutsch A; Neumeister P
PLoS One; 2015; 10(4):e0123922. PubMed ID: 25856582
[TBL] [Abstract][Full Text] [Related]
22. Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis.
Dorronsoro A; Lang V; Jakobsson E; Ferrin I; Salcedo JM; Fernández-Rueda J; Fechter K; Rodriguez MS; Trigueros C
Cell Death Dis; 2013 Dec; 4(12):e972. PubMed ID: 24357803
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis.
van Doorn R; Dijkman R; Vermeer MH; Out-Luiting JJ; van der Raaij-Helmer EM; Willemze R; Tensen CP
Cancer Res; 2004 Aug; 64(16):5578-86. PubMed ID: 15313894
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia.
Zhu L; Zhang F; Shen Q; Chen S; Wang X; Wang L; Yang L; Wu X; Huang S; Schmidt CA; Li Y
Hematology; 2014 Dec; 19(8):448-54. PubMed ID: 24611736
[TBL] [Abstract][Full Text] [Related]
25. [Immune regulation role of A20 and its clinical significance].
Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
[TBL] [Abstract][Full Text] [Related]
26. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
Vereecke L; Beyaert R; van Loo G
Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
[TBL] [Abstract][Full Text] [Related]
27. A20 is overexpressed in glioma cells and may serve as a potential therapeutic target.
Guo Q; Dong H; Liu X; Wang C; Liu N; Zhang J; Li B; Cao W; Ding T; Yang Z; Zhang X
Expert Opin Ther Targets; 2009 Jul; 13(7):733-41. PubMed ID: 19492975
[TBL] [Abstract][Full Text] [Related]
28. Intron-derived aberrant splicing of A20 transcript in rheumatoid arthritis.
Yoon HK; Byun HS; Lee H; Jeon J; Lee Y; Li Y; Jin EH; Kim J; Hong JH; Kim JH; Seok JH; Kang SW; Lee WH; Hur GM
Rheumatology (Oxford); 2013 Mar; 52(3):427-37. PubMed ID: 23148088
[TBL] [Abstract][Full Text] [Related]
29. DSIF restricts NF-κB signaling by coordinating elongation with mRNA processing of negative feedback genes.
Diamant G; Amir-Zilberstein L; Yamaguchi Y; Handa H; Dikstein R
Cell Rep; 2012 Oct; 2(4):722-31. PubMed ID: 23041311
[TBL] [Abstract][Full Text] [Related]
30. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.
Hirsch B; Grünbaum M; Wagner F; Bi Y; Lucka L; Du MQ; Stein H; Dürkop H
Histopathology; 2012 May; 60(6B):E19-27. PubMed ID: 22393903
[TBL] [Abstract][Full Text] [Related]
31. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
[TBL] [Abstract][Full Text] [Related]
32. An inhibitory effect of A20 on NF-kappaB activation in airway epithelium upon influenza virus infection.
Onose A; Hashimoto S; Hayashi S; Maruoka S; Kumasawa F; Mizumura K; Jibiki I; Matsumoto K; Gon Y; Kobayashi T; Takahashi N; Shibata Y; Abiko Y; Shibata T; Shimizu K; Horie T
Eur J Pharmacol; 2006 Jul; 541(3):198-204. PubMed ID: 16765340
[TBL] [Abstract][Full Text] [Related]
33. Characterization of bovine A20 gene: Expression mediated by NF-κB pathway in MDBK cells infected with bovine viral diarrhea virus-1.
Fredericksen F; Villalba M; Olavarría VH
Gene; 2016 May; 581(2):117-29. PubMed ID: 26809100
[TBL] [Abstract][Full Text] [Related]
34. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
35. Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
Krejsgaard T; Gjerdrum LM; Ralfkiaer E; Lauenborg B; Eriksen KW; Mathiesen AM; Bovin LF; Gniadecki R; Geisler C; Ryder LP; Zhang Q; Wasik MA; Odum N; Woetmann A
Leukemia; 2008 Dec; 22(12):2230-9. PubMed ID: 18769452
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
[TBL] [Abstract][Full Text] [Related]
39. A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
Cen H; Tan X; Guo B
PLoS One; 2015; 10(12):e0145037. PubMed ID: 26716984
[TBL] [Abstract][Full Text] [Related]
40. SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling.
León F; Cespón C; Franco A; Lombardía M; Roldán E; Escribano L; Harto A; González-Porqué P; Roy G
Leukemia; 2002 Aug; 16(8):1470-7. PubMed ID: 12145687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
